199 related articles for article (PubMed ID: 11179069)
1. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression.
Huber JD; Witt KA; Hom S; Egleton RD; Mark KS; Davis TP
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1241-8. PubMed ID: 11179069
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.
Huber JD; Hau VS; Borg L; Campos CR; Egleton RD; Davis TP
Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1531-7. PubMed ID: 12234806
[TBL] [Abstract][Full Text] [Related]
3. Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant.
Huber JD; Hau VS; Mark KS; Brown RC; Campos CR; Davis TP
Eur J Pharmacol; 2002 Aug; 450(3):297-304. PubMed ID: 12208323
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression.
Witt KA; Mark KS; Hom S; Davis TP
Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2820-31. PubMed ID: 12907427
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations.
Brooks TA; Hawkins BT; Huber JD; Egleton RD; Davis TP
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H738-43. PubMed ID: 15792985
[TBL] [Abstract][Full Text] [Related]
6. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain.
Brooks TA; Ocheltree SM; Seelbach MJ; Charles RA; Nametz N; Egleton RD; Davis TP
Brain Res; 2006 Nov; 1120(1):172-82. PubMed ID: 17007822
[TBL] [Abstract][Full Text] [Related]
7. Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier.
Campos CR; Ocheltree SM; Hom S; Egleton RD; Davis TP
Brain Res; 2008 Jul; 1221():6-13. PubMed ID: 18554577
[TBL] [Abstract][Full Text] [Related]
8. Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.
Lochhead JJ; McCaffrey G; Sanchez-Covarrubias L; Finch JD; Demarco KM; Quigley CE; Davis TP; Ronaldson PT
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H582-93. PubMed ID: 22081706
[TBL] [Abstract][Full Text] [Related]
9. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia.
McCaffrey G; Seelbach MJ; Staatz WD; Nametz N; Quigley C; Campos CR; Brooks TA; Davis TP
J Neurochem; 2008 Sep; 106(6):2395-409. PubMed ID: 18647175
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.
Ronaldson PT; Demarco KM; Sanchez-Covarrubias L; Solinsky CM; Davis TP
J Cereb Blood Flow Metab; 2009 Jun; 29(6):1084-98. PubMed ID: 19319146
[TBL] [Abstract][Full Text] [Related]
11. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution.
Hawkins BT; Abbruscato TJ; Egleton RD; Brown RC; Huber JD; Campos CR; Davis TP
Brain Res; 2004 Nov; 1027(1-2):48-58. PubMed ID: 15494156
[TBL] [Abstract][Full Text] [Related]
12. Diclofenac attenuates the regional effect of lambda-carrageenan on blood-brain barrier function and cytoarchitecture.
Brooks TA; Nametz N; Charles R; Davis TP
J Pharmacol Exp Ther; 2008 May; 325(2):665-73. PubMed ID: 18305016
[TBL] [Abstract][Full Text] [Related]
13. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo.
McCaffrey G; Staatz WD; Quigley CA; Nametz N; Seelbach MJ; Campos CR; Brooks TA; Egleton RD; Davis TP
J Neurochem; 2007 Dec; 103(6):2540-55. PubMed ID: 17931362
[TBL] [Abstract][Full Text] [Related]
14. [The tight junction proteins ZO-1, occludin and actin participate in the permeability increasing of blood-brain barrier induced by hypoxia-ischemia].
Wu LW; Yin F; Peng J; Wang WD; Gan N
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):513-6. PubMed ID: 18706176
[TBL] [Abstract][Full Text] [Related]
15. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation.
Mark KS; Davis TP
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1485-94. PubMed ID: 11893586
[TBL] [Abstract][Full Text] [Related]
16. Age and 17β-estradiol effects on blood-brain barrier tight junction and estrogen receptor proteins in ovariectomized rats.
Sandoval KE; Witt KA
Microvasc Res; 2011 Mar; 81(2):198-205. PubMed ID: 21192956
[TBL] [Abstract][Full Text] [Related]
17. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation.
Lochhead JJ; McCaffrey G; Quigley CE; Finch J; DeMarco KM; Nametz N; Davis TP
J Cereb Blood Flow Metab; 2010 Sep; 30(9):1625-36. PubMed ID: 20234382
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
[TBL] [Abstract][Full Text] [Related]
20. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
Musch MW; Walsh-Reitz MM; Chang EB
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
